Insider Transactions in Q2 2023 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 01
2023
|
William H Rastetter Director |
SELL
Open market or private sale
|
Direct |
4,300
-9.13%
|
$434,300
$101.43 P/Share
|
|
May 01
2023
|
William H Rastetter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,625
+13.94%
|
$91,500
$12.71 P/Share
|
|
May 01
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
11,397
-41.34%
|
$1,173,891
$103.89 P/Share
|
|
Apr 25
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
100
-0.36%
|
$10,300
$103.82 P/Share
|
|
Apr 24
2023
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,400
-35.08%
|
$1,483,200
$103.48 P/Share
|
|
Apr 21
2023
|
William H Rastetter Director |
SELL
Open market or private sale
|
Direct |
6,034
-13.26%
|
$633,570
$105.04 P/Share
|
|
Apr 21
2023
|
William H Rastetter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,765
+19.13%
|
$129,180
$12.71 P/Share
|
|
Apr 19
2023
|
William H Rastetter Director |
SELL
Open market or private sale
|
Direct |
903
-2.53%
|
$94,815
$105.0 P/Share
|
|
Apr 19
2023
|
William H Rastetter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,610
+4.32%
|
$19,320
$12.71 P/Share
|